Cannabidiol (CBD), a non-psychoactive component of the cannabis plant, has generated significant interest among scientists and physicians in recent years—but how CBD exerts its therapeutic impact on a molecular level is still being sorted out.
Cannabis terpenes interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the medicinal impact of the whole plant is greater than the sum of its parts.
Research on marijuana’s effects led directly to the discovery of a hitherto unknown biochemical communication system in the human body, the Endocannabinoid System, which plays a crucial role in regulating our physiology, mood, and everyday experience.
A groundbreaking study has documented the superior therapeutic properties of whole plant CBD-rich cannabis extract as compared to single-molecule CBD.
In a shorthand that drives scientists mad, serotonin is often called ‘the neurotransmitter of happiness.’ This tag is especially troublesome as more and more flaws become apparent in the ‘serotonin hypothesis’ of depression – the idea that depression is caused by a serotonin deficit, which a pill (a serotonin reuptake inhibitor) could correct.1 Serotonin is a complex molecule in the brain and the periphery with a vast and intricate
The huge popularity of cannabidiol (CBD), a non-intoxicating component of cannabis, has helped to destigmatize the plant and restore its reputation as an important medicinal herb.
The Massachusetts-based company Medicinal Genomics has sequenced the entire genome of Cannabis sativa L. The announcement received much attention. But how will it impact research and public health?
Project CBD speaks with Matt Elmes, PhD, director of new product development at CannaCraft, about his post-doctoral research on CBD, fatty acid transport molecules, and the endocannabinoid system.
Who is using CBD and why?
Despite the huge public interest in CBD products, and an endless stream of media stoking that fire, there have been limited efforts to figure out exactly how and why people are using this darling compound of the cannabis world.
The jury is out on the culprit(s) behind the recent outbreak of vaping related lung injury. In this special report, Project CBD’s Chief Science writer, Adrian Devitt-Lee, suggests that synthetic cannabinoids could be partially responsible.